本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Castle Biosciences, Inc.

23.53
-1.1700-4.74%
盤後23.530.00000.00%18:46 EDT
成交量:29.41萬
成交額:701.00萬
市值:7.00億
市盈率:-28.23
高:24.65
開:24.60
低:23.44
收:24.70
52周最高:44.28
52周最低:14.59
股本:2,973.12萬
流通股本:2,511.27萬
量比:0.97
換手率:1.17%
股息:- -
股息率:- -
每股收益(TTM):-0.8334
每股收益(LYR):-0.8334
淨資產收益率:-5.21%
總資產收益率:-2.56%
市淨率:1.49
市盈率(LYR):-28.23

資料載入中...

2021/03/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/11

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/08

重要事件披露

8-K - Current report
2021/02/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/13

重要事件披露

8-K - Current report
2020/12/22

重要事件披露

8-K - Current report
2020/12/16

重要事件披露

8-K - Current report
2020/12/14

重要事件披露

8-K - Current report
2020/11/09

重要事件披露

8-K - Current report
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/20

重要事件披露

8-K - Current report
2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/10

重要事件披露

8-K - Current report
2020/07/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership